Drug Shortage Report for JAMP-LEVETIRACETAM

Last updated on 2024-02-19 History
Report ID 164982
Drug Identification Number 02403005
Brand name JAMP-LEVETIRACETAM
Common or Proper name Levetiracetam Tablets USP
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) LEVETIRACETAM
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 120
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-07-19
Estimated end date 2025-12-31
Actual end date
Shortage status Actual shortage
Updated date 2024-02-19
Company comments new DIN available (02504553)
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2024-02-19 French Compare
v12 2024-02-19 English Compare
v11 2023-04-12 French Compare
v10 2023-04-12 English Compare
v9 2023-03-11 French Compare
v8 2023-03-11 English Compare
v7 2022-10-07 French Compare
v6 2022-10-07 English Compare
v5 2022-09-16 French Compare
v4 2022-09-16 English Compare
v3 2022-07-20 English Compare
v2 2022-07-19 French Compare
v1 2022-07-19 English Compare

Showing 1 to 13 of 13